Theracryf Plc

TCF Ordinary 0.05p
Create an alert
Sell0.16p
Buy0.18p
0.01p (2.86%)
Last updated today at
Trade

Key metrics

Open0.18p
Previous close0.18p
Market cap£3.65m
P/E ratio-
Volume2,531,884
Dividend yield0.00%
EMS1000000

Company information

TheraCryf plc is a clinical-stage drug development company focusing on brain disorders. The Company has a clinical and preclinical pipeline of indications, including addiction, anxiety, fatigue, narcolepsy, glioblastoma ...

  • LocationUnited Kingdom
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyGBP
  • Shares in issue2.73bn
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Accounts to trade in

Explore the accounts you can trade this stock in.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.